
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
EDITORIAL article
Front. Endocrinol. , 23 December 2016
Sec. Clinical Diabetes
Volume 7 - 2016 | https://doi.org/10.3389/fendo.2016.00166
This article is part of the Research Topic Sexual dimorphism in glucose and lipid metabolism View all 9 articles
Editorial on the Research Topic
Sexual Dimorphism in Glucose and Lipid Metabolism
Obesity and especially central obesity is associated with increased risk for development of type 2 diabetes and cardiovascular disease. Importantly, men have a greater amount of visceral adipose tissue than premenopausal women (Lundsgaard and Kiens; Varlamov et al.) and are more prone to develop pathological alterations in glucose and lipid metabolism (Lundsgaard and Kiens). Thus, understanding how sex influences energy metabolism might hold key answers to how obesity related diseases can be prevented. Therefore, the aim of this research topic is to give an overview of the current knowledge on sexual dimorphisms in glucose and lipid metabolism. The articles are mainly focused on knowledge obtained in humans using different tracer studies. Overall, the data point toward a complex role of sex hormones where the sexual dimorphisms depend on the metabolic status of the individual. This includes that women in the prandial and postprandial state utilize more carbohydrate than men to meet energy needs (Lundsgaard and Kiens), whereas during prolonged fasting or exercise women rely more on fat oxidation than men (Lundsgaard and Kiens; Varlamov et al.; Hedrington and Davis; Henderson; Santosa and Jensen) (summarized in Table 1).
Apart from the sexual dimorphism in when carbohydrates are preferred to meet energy needs, there are also sex differences in blood glucose levels (Hedrington and Davis). As reviewed by Hedrington and Davis, women endure lower blood glucose levels than men during prolonged fasting. This seems a consequence of a blunted central nervous system efferent response that in turn results in lower plasma levels of counter regulatory hormones and lower hepatic glucose output (Hedrington and Davis).
As reviewed by Santosa and Jensen, there are also substantial differences in lipid metabolism between men and women. Regional differences in FFA storage (Varlamov et al.; Santosa and Jensen) seem to contribute to the android (upper body)/gynoid (lower body) fat distribution (Table 1), whereas the role of depot differences in lipolytic rate is less clear (Varlamov et al.; Santosa and Jensen). However, there are sex differences in adipose tissue lipolysis during fasting and exercise, where women have a higher whole body lipolytic rate and higher plasma FFA levels than men (Lundsgaard and Kiens; Hedrington and Davis; Santosa and Jensen). In the postabsorptive state, most plasma triacylglycerol (TAG) is found in very low density lipoproteins (VLDL) secreted by the liver. Women have lower plasma levels of VLDL-TAG than men, which is due to a higher clearance rate of TAG by skeletal muscle (Lundsgaard and Kiens; Santosa and Jensen).
Insulin sensitivity is often measured as whole body insulin sensitivity and both no difference between men and women, and women having higher whole body insulin sensitivity than men have been reported (Varlamov et al.; Hedrington and Davis). Importantly, as reviewed by Lundsgaard and Kiens, the evidence for higher insulin sensitivity in female skeletal muscle stands stronger than the potential sexual dimorphism in whole body insulin sensitivity. Most studies investigating sex differences in insulin sensitivity have been conducted in healthy, lean individuals, thus leaving its significance in obese a largely unanswered question (Ter Horst et al.). In the study by Ter Horst et al., severely obese men had lower hepatic insulin sensitivity than BMI and age matched women, suggesting that targeting the liver when treating type-2-diabetes is particularly important in men.
How sex influences energy metabolism is highly complex and as pointed out in the review by Varlamov et al., even the gene-dosage effects of X and Y chromosomes should be taken into account. In addition to the effect on peripheral tissues, estrogen also directly influences the central nervous system and promotes anorexia through actions in hypothalamus (Varlamov et al.). Overall both estradiol and testosterone deficiency affects energy metabolism in a manner suggesting that both hormones have a protective role against obesity and insulin resistance (Varlamov et al.), with estradiol having the most pronounced effects (Santosa and Jensen). However, excess of both hormones, such as seen in women using oral contraceptives (excess exogenous estrogen) or women with PCOS (excess androgen), promotes insulin resistance (Lundsgaard and Kiens), and the beneficial effect of sex hormone repletion is generally unresolved (Santosa and Jensen).
In all, the articles underline the significance of sex differences in energy metabolism and show the importance of studying obesity related diseases in a sex-specific manner as conclusions made in one-sex studies only apply to that particular sex. Furthermore, much knowledge can be gained by understanding why premenopausal women despite a higher fat mass, remains less susceptible to obesity related diseases.
The author confirms being the sole contributor of this work and approved it for publication.
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported by a research grant from The Danish Diabetes Academy supported by the Novo Nordisk Foundation.
Keywords: sex, lipid metabolism, glucose metabolism, skeletal muscle, adipose tissue, liver, sex hormones
Citation: Lebeck J (2016) Editorial: Sexual Dimorphism in Glucose and Lipid Metabolism. Front. Endocrinol. 7:166. doi: 10.3389/fendo.2016.00166
Received: 16 March 2016; Accepted: 13 December 2016;
Published: 23 December 2016
Edited by:
Aaron Vinik, Eastern Virginia Medical School, USAReviewed by:
Dinesh Selvarajah, Sheffield Teaching Hospitals NHS Foundation Trust, UKCopyright: © 2016 Lebeck. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Janne Lebeck, amxAYmlvbWVkLmF1LmRr
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.